Krystal Biotech Inc
NASDAQ:KRYS

Watchlist Manager
Krystal Biotech Inc Logo
Krystal Biotech Inc
NASDAQ:KRYS
Watchlist
Price: 177.39 USD -3.71% Market Closed
Market Cap: 5.1B USD
Have any thoughts about
Krystal Biotech Inc?
Write Note

Krystal Biotech Inc
Total Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Krystal Biotech Inc
Total Equity Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Total Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Equity CAGR 3Y CAGR 5Y CAGR 10Y
Krystal Biotech Inc
NASDAQ:KRYS
Total Equity
$885.8m
CAGR 3-Years
29%
CAGR 5-Years
34%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Total Equity
$6B
CAGR 3-Years
-24%
CAGR 5-Years
N/A
CAGR 10-Years
3%
Gilead Sciences Inc
NASDAQ:GILD
Total Equity
$18.4B
CAGR 3-Years
-5%
CAGR 5-Years
-2%
CAGR 10-Years
3%
Amgen Inc
NASDAQ:AMGN
Total Equity
$7.5B
CAGR 3-Years
-3%
CAGR 5-Years
-7%
CAGR 10-Years
-11%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Total Equity
$15.6B
CAGR 3-Years
18%
CAGR 5-Years
24%
CAGR 10-Years
30%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Total Equity
$29.3B
CAGR 3-Years
19%
CAGR 5-Years
23%
CAGR 10-Years
28%

See Also

What is Krystal Biotech Inc's Total Equity?
Total Equity
885.8m USD

Based on the financial report for Sep 30, 2024, Krystal Biotech Inc's Total Equity amounts to 885.8m USD.

What is Krystal Biotech Inc's Total Equity growth rate?
Total Equity CAGR 5Y
34%

Over the last year, the Total Equity growth was 17%. The average annual Total Equity growth rates for Krystal Biotech Inc have been 29% over the past three years , 34% over the past five years .

Back to Top